News

First monoclonal antibody therapy for prevention of migraine

INDUSTRY, MEDICAL COMMUNITY, News / By

First monoclonal antibody therapy for prevention of Migraine Aimovig recommended for marketing authorization 01/06/2018 The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Aimovig (erenumab), the first human monoclonal antibody therapy for prevention of migraine. Aimovig belongs to a new class of medicines that work by blocking the activity […]

First monoclonal antibody therapy for prevention of migraine Read More »

Arnold Neuralgia/Recurrent occipital pain cause

MEDICAL COMMUNITY, News, PATIENTS / By

Recurrent, troublesome occipital pain associated with muscular tension is known as Arnold’s neuralgia, a strange condition. The condition of peripheral nerves can produce the pain of varying intensity as a reflex mechanism, depending on the degree of damage being considered. Some anatomical locations are often associated with these syndromes, with the exception of the occipital

Arnold Neuralgia/Recurrent occipital pain cause Read More »

Cluster headache: Galcanezumab

INDUSTRY, MEDICAL COMMUNITY, News, PATIENTS / By

Cluster headache: Galcanezumab Prevention of episodic cluster headache: Primary endpoint achieved in Phase 3 study 16/05/2018 Eli Lilly and Company announced that Galcanezumab met with the primary endpoint in a Phase 3 trial of episodic cluster headache patients, the statistically significant differences in reducing headache attacks. In weekly clusters compared to placebo during the weeks

Cluster headache: Galcanezumab Read More »

EPF publishes a guide for patient organisations on the new Data Protection Regulation

Associations, News / By

The new Regulation on personal data protection (EU/2016/679) was published in May 2016 and will apply from May 2018. It provides more rights to citizens to be better informed about the use made of their personal data, and gives clearer responsibilities to people and entities using personal data. Patients’ fundamental right to protection of their health data

EPF publishes a guide for patient organisations on the new Data Protection Regulation Read More »

Migraine and genetic

MEDICAL COMMUNITY, News, PATIENTS / By

Migraine and genetic Migraine is associated with a polygenic inheritance Migraines and genetic: A new study has found that some families are especially sensitive to Migraines and that genetics influences the type of migraine suffered by affected people. Migraine is a disease that has as its main symptom headache, throbbing, unilateral, accompanied by nausea or

Migraine and genetic Read More »

CGRP as the target of new migraine therapies

INDUSTRY, MEDICAL COMMUNITY, News, PATIENTS / By

CGRP as the target of new migraine therapies — successful translation from bench to clinic You can now download the document here:  —–>  CGRP as the target of new migraine therapies — successful translation from bench to clinic Treatment of migraine is on the cusp of a new era with the development of drugs that target

CGRP as the target of new migraine therapies Read More »

European Patients’ Rights Day, TODAY, April 18

Associations, News, PATIENTS, PATIENTS ASSOCIATIONS, POLICY MAKERS / By

Patients claim their right to participate in Decision about their Health Patients have the right to participate in making decisions about their health, either through patient organizations in public policies that affect them or through the sharing of information and consensus with their doctor, for example, about what treatment to follow. This is one of

European Patients’ Rights Day, TODAY, April 18 Read More »

logo-emha-footer
MENU
LASTEST NEWS
ALL NEWS
SOCIAL
Facebook Instagram Twitter Youtube
Scroll to Top

FOR YOU

Working together we can achieve a better future for all patients living with migraine.

Facebook Instagram Twitter Youtube
Search
Close this search box.
Facebook Instagram Twitter Youtube